Medical Economics Logo
  • Physicians Money Digest

  • Physicians Financial News

  • Physicians Practice

  • Chief Healthcare Executive

  • Patient Care Online

All NewsCareersLegalMoneyOpinionPhysicians Financial NewsPractice ManagementTechnology
Around the PracticeBetween The LinesClinical ConsultExpert InterviewsMedical Economics PulseMedical World NewsOff The Charts PodcastsPhysician ReportPrimaryViewSlideshows
Academy
Conference CoverageConference Listing
Medical EconomicsPatient Care SupplementSponsored ContentSponsored ResourcesSupplements And Featured Publications
CME/CEJob BoardSubscribe
Financial Advisor Guide
CareersCareersCareersCareersCareersCareersCareersCareersCareers
LegalLegalLegalLegalLegal
Medical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & Technology
Opinion
Physician's Money DigestPhysician's Money DigestPhysician's Money DigestPhysician's Money Digest
PolicyPolicyPolicyPolicyPolicyPolicy
Practice FinancePractice FinancePractice FinancePractice FinancePractice FinancePractice FinancePractice Finance
Practice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice Management
Practice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice Technology
Screening
Special ReportsSpecial ReportsSpecial Reports
Spotlight -
  • The benefits of a physician MBA program
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Physician Bootcamp
  • Physician Report
CareersCareersCareersCareersCareersCareersCareersCareersCareers
LegalLegalLegalLegalLegal
Medical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & TechnologyMedical Device & Technology
Opinion
Physician's Money DigestPhysician's Money DigestPhysician's Money DigestPhysician's Money Digest
PolicyPolicyPolicyPolicyPolicyPolicy
Practice FinancePractice FinancePractice FinancePractice FinancePractice FinancePractice FinancePractice Finance
Practice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice ManagementPractice Management
Practice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice TechnologyPractice Technology
Screening
Special ReportsSpecial ReportsSpecial Reports
    • Academy
    • CME/CE
    • Job Board
    • Subscribe
Advertisement

Publication

Article

May 2, 2018

Medical Economics Journal

Vol. 95 No 08
Volume95
Issue 08

Manage rheumatoid arthritis and related quality metrics

Author(s):

Lisa Eramo, MA

Prescribing a disease-modifying anti-rheumatic drug (DMARD) for patients with rheumatoid arthritis not only helps alleviate symptoms, but it may also help physicians trigger performance-based bonuses from certain commercial payers.

This article appears in the 5/10/18 issue of Medical Economics

Approximately 1.5 million people in the United States have rheumatoid arthritis, according to the Arthritis Foundation. Prescribing a disease-modifying anti-rheumatic drug (DMARD) for patients with rheumatoid arthritis not only helps alleviate symptoms, but it may also help physicians trigger performance-based bonuses from certain commercial payers.
That’s because rheumatoid arthritis is a condition included in the 2018 Healthcare Effectiveness Data and Information Set (HEDIS), a tool used by more than 90 percent of commercial insurers to measure physicians’ performance on care and service.
Many payers tie physician bonuses directly to their ability to satisfy HEDIS requirements-in this case, the ability to dispense at least one ambulatory prescription for a disease-modifying anti-rheumatic drug for patients with rheumatic arthritis ages 18 and older

Prescribing  DMARDs

Early intervention is critical for patients with rheumatoid arthritis, and it’s also something that payers increasingly must report as a HEDIS measure. If physicians can show that they provide high-quality, evidence-based care-either through prescribing DMARDs or working with rheumatologists to co-manage care-payers might provide physicians with a performance bonus, says Colleen Gianatasio CPC, CRC, risk adjustment quality and education program manager at Capital District Physician’s Health Plan in Albany, N.Y.
Physicians-particularly those in rural areas without easy access to rheumatologists-need to feel comfortable recognizing the signs and symptoms so they can prescribe first-line standard medications, such as methotrexate, says Fotios Koumpouras, MD, a rheumatologist and assistant professor of medicine at Yale University. 
“The first thing is to pick up the phone and call the rheumatologist,” he says. “A quick phone call can actually make the internist feel more comfortable to initiate a treatment plan.”
Nitin Damle, MD, an internist in Wakefield, R.I., agrees. “The more we can communicate with rheumatologists, the better we can be at managing the problems that arise,” he says. “If we need to change a medication, for example, that’s much easier to do when there’s a collegial relationship.”
Having a collegial relationship with rheumatologists not only helps physicians meet MIPS and HEDIS measures, it can also assist with Accountable Care Organization (ACO) quality reporting, says Gregory Steinmetz, MD, a primary care physician at Associates Primary Care Medicine in Warwick, R.I.
For example, to fulfill its obligations under an ACO contract, Steinmetz’s practice previously had to report whether patients with rheumatoid arthritis were prescribed a DMARD. Insurers sent the practice lists of patients diagnosed with rheumatoid arthritis, and someone from the practice had to call each patient’s rheumatologist to obtain documentation confirming DMARD treatment. Creating a relationship that promotes the ongoing exchange of information can help practices meet this quality metric more easily, he says.
Chronic care management (CCM) programs can help open the lines of communication with rheumatologists to obtain this information, says Gianatasio. That’s because with CCM, practices have already created workflows that promote frequent communication with specialists who help co-manage chronic conditions, including arthritis. “We really encourage communications between our primary care physicians and specialists,” she says. “We still see a major gap between them. At least once a year, you really should be asking for charts from the specialist.”

Articles in this issue

Health IT: Technology innovations for your practice
Health IT: Technology innovations for your practice
Boost MIPS scores while improving osteoarthritis patient management
Boost MIPS scores while improving osteoarthritis patient management
Manage rheumatoid arthritis and related quality metrics
Manage rheumatoid arthritis and related quality metrics
©Scott Hales / Shutterstock
Navigating cost-of-care conversations with patients
©Fer_Gregory/Shutterstock.com
Understand, prepare for 2018 tax changes
Coding case study: Sinusitis
Coding case study: Sinusitis

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Subscribe Now!
Related Videos
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
Succeeding in value-based payment: A conversation with Joshua M. Liao, MD
ACP policy update 2025: A conversation with Brian E. Outland, PhD
ACP policy update 2025 interview
ACP policy update 2025 interview
ACP policy update 2025 interview
Related Content
Advertisement
© RXNT
July 8th 2025

Proactive denial management: A revenue game changer for small practices

Zed Williamson and the Physician Growth Accelerator Podcast featured on Medical Economics
June 21st 2025

The peril of relying on one person at your practice

Tammy Schaeffer: ©Plante Moran
June 30th 2025

A decade of value-based care: Tammy Schaeffer, JD, RN

Zed Williamson and the Physician Growth Accelerator Podcast featured on Medical Economics
June 5th 2025

How behavior patterns drive or derail your practice

Understand who you are selling your medical practice to before you sign: ©KMPZZZ - stock.adobe.com
June 25th 2025

How to understand the difference among potential buyers of your medical practice

How pay-first and direct primary care models are reshaping practice finances and patient experience - Hari Prasad, founder and CEO of Yosi Health
June 25th 2025

How pay-first and direct primary care models are reshaping practice finances and patient experience

Related Content
Advertisement
© RXNT
July 8th 2025

Proactive denial management: A revenue game changer for small practices

Zed Williamson and the Physician Growth Accelerator Podcast featured on Medical Economics
June 21st 2025

The peril of relying on one person at your practice

Tammy Schaeffer: ©Plante Moran
June 30th 2025

A decade of value-based care: Tammy Schaeffer, JD, RN

Zed Williamson and the Physician Growth Accelerator Podcast featured on Medical Economics
June 5th 2025

How behavior patterns drive or derail your practice

Understand who you are selling your medical practice to before you sign: ©KMPZZZ - stock.adobe.com
June 25th 2025

How to understand the difference among potential buyers of your medical practice

How pay-first and direct primary care models are reshaping practice finances and patient experience - Hari Prasad, founder and CEO of Yosi Health
June 25th 2025

How pay-first and direct primary care models are reshaping practice finances and patient experience

About
Advertise
Contact Us
Editorial Staff
Job Board
Terms and Conditions
Contributor Guidelines
Privacy Policy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.